Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Anastrozole
Sponsor: AstraZeneca